279 research outputs found
The accretion and spreading of matter on white dwarfs
For a slowly rotating non-magnetized white dwarf the accretion disk extends
all the way to the star. Here the matter impacts and spreads towards the poles
as new matter continuously piles up behind it. We have solved the 3d
compressible Navier-Stokes equations on an axisymmetric grid to determine the
structure of this boundary layer for different viscosities corresponding to
different accretion rates. The high viscosity cases show a spreading BL which
sets off a gravity wave in the surface matter. The accretion flow moves
supersonically over the cusp making it susceptible to the rapid development of
gravity wave and/or Kelvin-Helmholtz instabilities. This BL is optically thick
and extends more than 30 degrees to either side of the disk plane after 3/4 of
a Keplerian rotation period (t=19s). The low viscosity cases also show a
spreading BL, but here the accretion flow does not set off gravity waves and it
is optically thin.Comment: 6 pages, 5 figures, requires autart.cl
The paranasal sinuses are focus for colonisation and chronic biofilm lung infection in CF patients
n/
Household experience and costs of seeking measles vaccination in rural Guinea-Bissau.
OBJECTIVES: Children younger than 12 months of age are eligible for childhood vaccines through the public health system in Guinea-Bissau. To limit open vial wastage, a restrictive vial opening policy has been implemented; 10-dose measles vaccine vials are only opened if six or more children aged 9-11 months are present at the vaccination post. Consequently, mothers who bring their child for measles vaccination can be told to return another day. We aimed to describe the household experience and estimate household costs of seeking measles vaccination in rural Guinea-Bissau. METHODS: Within a national sample of village clusters under demographic surveillance, we interviewed mothers of children aged 9-21 months about their experience with seeking measles vaccination. From information about time and money spent, we calculated household costs of seeking measles vaccination. RESULTS: We interviewed mothers of 1308 children of whom 1043 (80%) had sought measles vaccination at least once. Measles vaccination coverage was 70% (910/1308). Coverage decreased with increasing distance to the health centre. On average, mothers who had taken their child for vaccination took their child 1.4 times. Mean costs of achieving 70% coverage were 2.04 USD (SD 3.86) per child taken for vaccination. Half of the mothers spent more than 2 h seeking vaccination and 11% spent money on transportation. CONCLUSIONS: We found several indications of missed opportunities for measles vaccination resulting in suboptimal coverage. The household costs comprised 3.3% of the average monthly income and should be taken into account when assessing the costs of delivering vaccinations
Eff ects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival:an observational study
Background In 2008, the GAVI Alliance funded the introduction of new vaccines (including pentavalent diphtheriatetanus-
pertussis [DTP] plus hepatitis B and Haemophilus infl uenzae type b antigens) in Guinea-Bissau. The
introduction was accompanied by increased vaccination outreach services and a more restrictive wastage policy,
including only vaccinating children younger than 12 months. We assessed coverage of all vaccines in the Expanded
Program on Immunizations before and after the new vaccines’ introduction, and the implications on child survival.
Methods This observational cohort study used data from the Bandim Health Project, which has monitored vaccination
status and mortality in randomly selected village clusters in Guinea-Bissau since 1990. We assessed the change in
vaccination coverage using cohort data from children born in 2007 and 2009; analysed the proportion of children who
received measles vaccine after 12 months of age using data from 1999–2006; and compared child mortality after age
12 months in children who had received measles vaccine and those who had not using data from 1999 to 2006.
Findings The proportion of children who were fully vaccinated by 12 months of age was 53% (468 of 878) in the 2007
cohort and 53% (467 of 879) in the 2009 cohort (relative risk [RR] 1·00, 95% CI 0·89–1·11). Coverage of DTP-3 and
pentavalent-3 increased from 73% (644 of 878) in 2007 to 81% (712 of 879) in 2009 (RR 1·10, 95% CI 1·04 –1·17); by
contrast, the coverage of measles vaccination declined from 71% (620 of 878) to 66% (577 of 879; RR 0·93, 0·85–1·01).
The eff ect of the changes was signifi cantly diff erent for DTP-3 coverage compared with measles vaccine coverage
(p=0·002). After 12 months of age, the adjusted mortality rate ratio was 0·71 (95% CI 0·56–0·90) for children who had
received measles vaccine compared with those who had not (0·59 [0·43–0·80] for girls and 0·87 [0·62–1·23] for boys).
Interpretation The introduction of the new vaccination programme in 2008 was associated with increased coverage
of DTP, but decreased coverage of measles vaccine. In 1999–2006, child mortality was higher in children who had
not received measles vaccine than in those who had
Research protocol of two concurrent cluster-randomized trials:Real-life Effect of a CAMPaign with Measles Vaccination (RECAMP-MV) and Real-life Effect of a CAMPaign with Oral Polio Vaccination (RECAMP-OPV) on mortality and morbidity among children in rural Guinea-Bissau
Interaction between neonatal vitamin A supplementation and timing of measles vaccination: a retrospective analysis of three randomized trials from Guinea-Bissau.
BACKGROUND: In Guinea-Bissau we conducted three trials of neonatal vitamin A supplementation (NVAS) from 2002 to 2008. None of the trials found a beneficial effect on mortality. From 2003 to 2007, an early measles vaccine (MV) trial was ongoing, randomizing children 1:2 to early MV at 4.5 months or no early MV, in addition to the usual MV at 9 months. We have previously found interactions between vitamin A and vaccines. OBJECTIVE: We investigated whether there were interactions between NVAS and early MV. DESIGN: We compared the mortality of NVAS and placebo recipients: first, from 4.5 to 8 months for children randomized to early MV or no early MV; and second, from 9 to 17 months in children who had received two MV or one MV. Mortality rates (MR) were compared in Cox models producing mortality rate ratios (MRR). RESULTS: A total of 5141 children were randomized to NVAS (N=3015) or placebo (N=2126) and were later randomized to early MV (N=1700) or no early MV (N=3441). Between 4.5 and 8 months, NVAS compared with placebo was associated with higher mortality in early MV recipients (MR=30 versus MR=0, p=0.01), but not in children who did not receive early MV (p for interaction between NVAS and early MV=0.03). From 9 to 17 months NVAS was not associated with mortality. Overall, from 4.5 to 17 months NVAS was associated with increased mortality in early MV recipients (Mortality rate ratio=5.39 (95% confidence interval: 1.62, 17.99)). CONCLUSIONS: These observations indicate that NVAS may interact with vaccines given several months later. This may have implications for the planning of future child intervention programs
Does oral polio vaccine have non-specific effects on all-cause mortality? Natural experiments within a randomised controlled trial of early measles vaccine.
BACKGROUND: BCG and measles vaccine (MV) may have beneficial non-specific effects (NSEs). If an unplanned intervention with a vaccine (a natural experiment) modifies the estimated effect in a randomised controlled trial (RCT), this suggests NSEs. We used this approach to test NSEs of triple oral polio vaccine (OPV). METHODS: During an RCT of 2 doses of MV at 4.5 and 9 months versus 1 dose of MV at 9 months of age, we experienced 2 natural experiments with OPV. We assessed whether these OPV experiments modified the effect of 2-dose MV in the MV trial. SETTING: MV RCT conducted in urban Guinea-Bissau 2003-2009. INTERVENTIONS: Natural experiments with OPV due to missing vaccine and the implementation of OPV campaigns. MAIN OUTCOME MEASURE: Changes in the mortality rate ratio (MRR) for 2-dose MV versus 1-dose MV. RESULTS: First, the MRR (2-dose/1-dose MV) overall was 0.70 (0.52 to 0.94), but the MRR was 1.04 (0.53 to 2.04) when OPV at birth (OPV0) was not given, suggesting that early priming with OPV was important for the effect of 2-dose MV. The effect of OPV0 depended on age of administration; the MRR (2-dose/1-dose MV) was 0.45 (0.29 to 0.71) for children receiving OPV0 in the first week of life, but 3.63 (0.87 to 15.2) for those receiving OPV0 after the first month of life (p=0.007, test of no interaction). Second, campaign-OPV may have reduced the difference between the randomisation groups since the MRR (2-dose/1-dose MV) was 0.60 (0.42 to 0.85) for children who had not received campaign-OPV before RCT-enrolment versus 0.72 (0.23 to 2.31) and 1.42 (0.70 to 2.90) for children who had received 1 or 2 doses of campaign-OPV-before-enrolment, respectively. CONCLUSIONS: Bissau had no polio infection during this trial, so OPV0 and campaign-OPV may have NSEs since they modified the effect of 2-dose MV in an RCT. Different interventions may interact to a much larger effect than usually assumed
Models for Type I X-Ray Bursts with Improved Nuclear Physics
Multi-zone models of Type I X-ray bursts are presented that use an adaptive
nuclear reaction network of unprecedented size, up to 1300 isotopes. Sequences
of up to 15 bursts are followed for two choices of accretion rate and
metallicity. At 0.1 Eddington (and 0.02 Eddington for low metallicity),
combined hydrogen-helium flashes occur. The rise times, shapes, and tails of
these light curves are sensitive to the efficiency of nuclear burning at
various waiting points along the rp-process path and these sensitivities are
explored. The bursts show "compositional inertia", in that their properties
depend on the fact that accretion occurs onto the ashes of previous bursts
which contain left-over hydrogen, helium and CNO nuclei. This acts to reduce
the sensitivity of burst properties to metallicity. For the accretion rates
studied, only the first anomalous burst in one model produces nuclei as heavy
as A=100, other bursts make chiefly nuclei with A~64. The amount of carbon
remaining after hydrogen-helium bursts is typically <1% by mass, and decreases
further as the ashes are periodically heated by subsequent bursts. At the lower
accretion rate of 0.02 Eddington and solar metallicity, the bursts ignite in a
hydrogen-free helium layer. At the base of this layer, up to 90% of the helium
has already burned to carbon prior to the unstable ignition. These
helium-ignited bursts have briefer, brighter light curves with shorter tails,
very rapid rise times (<0.1 s), and ashes lighter than the iron group.Comment: Submitted to the Astrophysical Journal (42 pages; 27 figures
- …